ENTITY
Clinuvel Pharmaceuticals

Clinuvel Pharmaceuticals (CUV AU)

89
Analysis
Health CareAustralia
Clinuvel Pharmaceuticals Limited is an Australian biopharmaceutical company. The company focused on developing dermatology pharmaceutical products for a range of UV-related skin disorders. Clinuvel's work aims at preventing the symptoms of diseases related to harmful UV radiation.
more
25 Sep 2024 12:09

Clinuvel: A Big Future in Skin Disease Treatment

Clinuvel is a strong investment due to its monopoly on the only approved EPP treatment (Scenesse), patent protection, orphan drug status, solid...

Logo
226 Views
Share
07 Jul 2024 00:53

Clinuvel Pharmaceuticals (CUV AU): Positive Clinical Trial Result; Base Business Going Strong

​Clinuvel Pharmaceuticals reported positive results from CUV151 study on DNA-repair capacity of afamelanotide. Expanding patient reach of Scenesse...

Logo
410 Views
Share
21 Jun 2024 19:04Broker

Clinuvel Pharmaceuticals (CUV): Looking to Vitiligo

Reviewing vitiligo expectations, Phase 3 readout CY25CUV are conducting two Phase 3 trials to expand the label of Scenesse to include patients with...

Logo
412 Views
Share
16 Aug 2024 06:00

ASX Short Interest Weekly (Aug 9th): CSL, Qbe Insurance, Macquarie, Agl Energy, Telstra

We analyzed ASX short interest report for the past week and highlight short interest changes in CSL, Qbe Insurance, Macquarie, Agl Energy, Telstra.

Logo
218 Views
Share
09 Aug 2024 06:00

ASX Short Interest Weekly (Aug 2nd): Westgold Resourc, Seek, Paladin Energy, Fortescue, ANZ, Altium

We analyzed ASX short interest report for the past week and highlight short interest changes in Westgold Resourc, Seek, Paladin Energy, Fortescue,...

Logo
147 Views
Share
x